-
DE
Sequence-based diagnostics analyzes the DNA or RNA sequence of an organism to detect diseases, identify pathogens, and precisely characterize genetic alterations.
Sequence-based diagnostics analyzes the DNA or RNA sequence of an organism to detect diseases, identify pathogens, and precisely characterize genetic alterations.
Sequence-based diagnostics is a modern approach in laboratory medicine and molecular biology that determines the precise order of nucleotides – the DNA or RNA sequence – of an organism, pathogen, or human genome. Using state-of-the-art sequencing technologies, genetic information is read and analyzed with high accuracy. The resulting data allows clinicians to draw conclusions about diseases, pathogen types, resistance mechanisms, and individual genetic risk profiles.
Several technology generations and approaches are used in sequence-based diagnostics:
Sanger sequencing is one of the oldest and most well-established methods. It is suitable for targeted analysis of individual genes or short DNA segments and is considered the gold standard for confirming point mutations.
Next-Generation Sequencing (NGS), also known as high-throughput sequencing, enables the parallel sequencing of millions of DNA fragments simultaneously. It is used for:
Nanopore sequencing is a newer technology capable of reading long DNA strands in real time. It is increasingly used for rapid pathogen identification, for example during outbreak situations.
Sequence-based diagnostics is applied across numerous medical disciplines:
By sequencing the genetic material of bacteria, viruses, or fungi, pathogens can be precisely identified, outbreak chains can be traced, and antibiotic resistance mechanisms can be detected at the genetic level. This was of major importance during the COVID-19 pandemic for variant surveillance.
In cancer diagnostics, sequencing enables the identification of somatic mutations, gene fusions, and copy number variations in tumor cells. This is critical for selecting targeted therapies (precision oncology) and assessing treatment response.
In cases of unexplained illness, particularly in children, exome or genome sequencing enables the identification of germline mutations responsible for rare hereditary conditions. The diagnostic yield in this patient group ranges from 25 to 50 percent depending on the study.
Non-invasive prenatal tests (NIPT) use sequence-based methods to analyze cell-free fetal DNA in maternal blood and detect chromosomal abnormalities such as trisomy 21 at an early stage.
Sequence-based diagnostics can identify genetic variants that influence individual responses to specific medications, supporting personalized prescribing with optimal efficacy and reduced risk of adverse effects.
The typical workflow of a sequence-based diagnostic investigation includes the following steps:
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.